Prosecution Insights
Prosecution Insights
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §102 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEHARRY, ZANNA MARIA | 1 | 22.7% | +50.5% |
| HOFFMAN, SUSAN COE | 1 | 54.1% | +25.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18836116 | Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte | BEHARRY, ZANNA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18836116 | Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte | BEHARRY, ZANNA MARIA | — |
| 17602644 | THERAPEUTIC AGENT FOR FIBROSIS, INFLAMMATION, AND/OR AGING DISEASE | HOFFMAN, SUSAN COE | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18836116 | Method for Inducing Differentiation from Pluripotent Stem Cell to Epidermal Keratinocyte | BEHARRY, ZANNA MARIA | — | §102 | Non-Final OA | — | Pending | Aug 06, 2024 |
| 17602644 | THERAPEUTIC AGENT FOR FIBROSIS, INFLAMMATION, AND/OR AGING DISEASE | HOFFMAN, SUSAN COE | 1655 | §103 | Non-Final OA | — | Pending | Oct 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial